Jane Street’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.7M Buy
244,200
+78,500
+47% +$8.07M ﹤0.01% 1713
2025
Q4
$15.8M Sell
165,700
-9,400
-5% -$947K ﹤0.01% 1824
2025
Q3
$17.3M Buy
175,100
+2,600
+2% +$278K ﹤0.01% 1797
2025
Q2
$18.4M Buy
172,500
+83,900
+95% +$8.47M ﹤0.01% 1531
2025
Q1
$8.07M Sell
88,600
-5,000
-5% -$560K ﹤0.01% 2271
2024
Q4
$10.7M Sell
93,600
-20,700
-18% -$2.36M ﹤0.01% 1828
2024
Q3
$13.6M Sell
114,300
-14,700
-11% -$1.35M ﹤0.01% 1608
2024
Q2
$10.4M Buy
129,000
+17,000
+15% +$1.55M ﹤0.01% 2017
2024
Q1
$10.3M Sell
112,000
-52,300
-32% -$5.01M ﹤0.01% 1779
2023
Q4
$17.3M Buy
164,300
+10,900
+7% +$1.1M ﹤0.01% 1399
2023
Q3
$16.7M Sell
153,400
-9,800
-6% -$1.08M 0.01% 1260
2023
Q2
$17.6M Buy
163,200
+34,700
+27% +$3.9M 0.01% 1336
2023
Q1
$16M Sell
128,500
-52,500
-29% -$7.21M 0.01% 1185
2022
Q4
$27.2M Buy
181,000
+37,100
+26% +$5.71M 0.01% 813
2022
Q3
$19.4M Sell
143,900
-155,800
-52% -$23.8M 0.01% 1095
2022
Q2
$44.7M Sell
299,700
-133,500
-31% -$20.4M 0.02% 605
2022
Q1
$73.9M Buy
433,200
+28,700
+7% +$4.82M 0.02% 509
2021
Q4
$104M Sell
404,500
-349,500
-46% -$95.7M 0.03% 354
2021
Q3
$206M Buy
754,000
+451,400
+149% +$143M 0.07% 161
2021
Q2
$67.7M Buy
302,600
+164,300
+119% +$31M 0.03% 425
2021
Q1
$15.1M Sell
138,300
-110,700
-44% -$11.8M 0.01% 1202
2020
Q4
$20.3M Buy
249,000
+42,600
+21% +$4.18M 0.01% 858
2020
Q3
$14.2M Buy
206,400
+161,000
+355% +$11.6M 0.01% 969
2020
Q2
$3.04M Buy
+45,400
New +$2.27M ﹤0.01% 2488

Other funds holding BNTX

Jane Street's BNTX Position: Q1 2026 in Review

Jane Street reduced its BioNTech (BNTX) stake by 75% in Q1 2026, selling an estimated $105M and leaving 336,757 shares worth $29.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1448.

Jane Street first reported a position in BNTX in Q1 2020 and has held it in 24 quarters since. The position peaked at $130M in Q4 2025. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Jane Street held 336,757 shares of BioNTech worth $29.9M as of Q1 2026.
  • Jane Street sold 1,024,464 BioNTech shares in Q1 2026, an estimated $105M.
  • BioNTech made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #1448 holding.
  • Jane Street first reported a position in BioNTech in Q1 2020 and has held it in 24 quarters since.
  • Jane Street's BioNTech position peaked at $130M in Q4 2025.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.